 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper129th MAINE LEGISLATURE
SECOND REGULAR SESSION-2020
Legislative Document No. 2153
S.P. 779 In Senate,  March  12, 2020
An Act  To Establish an  Accidental Drug Overdose Death  Review 
Panel
(EMERGENCY)
Reference to the Committee on Judiciary  suggested and ordered  printed.
DAREK M.  GRANT
Secretary of the Senate
Presented by Senator CARPENTER  of Aroostook.  (GOVERNOR'S BILL)

Page 1 - 129LR3253(01)-11Emergency preamble. Whereas, acts and resolves of the Legislature do not 
2become effective until 90 days after adjournment unless enacted as emergencies; and
3Whereas, the number of individuals residing in Maine who die as the result of an 
4accidental drug overdose is increasing and exceeds the national average on a per capita 
5basis; and
6Whereas, this legislation must take effect before the expiration of the 90-day period 
7to help prevent, as soon as possible, accidental drug overdose deaths; and
8Whereas, in the judgment of the Legislature, these facts create an emergency within 
9the meaning of the Constitution of Maine and require the following legislation as 
10immediately necessary for the preservation of the public peace, health and safety; now, 
11therefore,
12Be it enacted by the People of the State of Maine as follows:
13Sec. 1.  5 MRSA ยง200-M is enacted to read:
14ยง200-M.  Accidental Drug Overdose Death Review Panel
15There is created, within the Office of the Attorney General, the Accidental Drug 
16Overdose Death Review Panel, referred to in this section as "the panel," in order to 
17recommend to state, county and local agencies methods of preventing deaths as the result 
18of accidental drug overdoses including modification or enactment of laws, rules, policies 
19and procedures.
201.  Composition.  The panel consists of the following members:
21A.  The Chief Medical Examiner, ex officio;
22B.  The Commissioner of Public Safety, ex officio;
23C.  The director of the office of substance abuse and mental health services within the 
24Department of Health and Human Services, ex officio;
25D.  The Director of the Maine Center for Disease Control and Prevention within the 
26Department of Health and Human Services, ex officio;
27E.  The Chief Justice of the Supreme Judicial Court, ex officio;
28F.  A prosecutor, nominated by a statewide association of prosecutors and appointed 
29by the Attorney General;
30G.  A police chief, nominated by a statewide association of chiefs of police and 
31appointed by the Attorney General;
32H.  A sheriff, nominated by a statewide association of sheriffs and appointed by the 
33Attorney General;
34I.  One or more physicians who treat substance use disorder, appointed by the 
35Governor;
Page 2 - 129LR3253(01)-11J.  An emergency medical services representative, appointed by the Commissioner of 
2Public Safety;
3K.  An expert in harm reduction strategies, appointed by the Governor;
4L.  An academic research professor with experience in reviewing drug overdose 
5deaths, appointed by the Attorney General;
6M.  One or more representatives of families affected by drug overdose deaths, 
7appointed by the Governor; and
8N.  The director of opioid response within the Governor's Office of Policy Innovation 
9and the Future, who shall chair the panel.
10The Attorney General and the Governor may each appoint additional members of the 
11panel.
122.  Designees; terms of office.  An ex officio member may appoint a designee to 
13represent the ex officio member on the panel.  A designee, once appointed, qualifies as a 
14full voting member of the panel and may hold office and enjoy all the other rights and 
15privileges of full membership on the panel.  Appointed members of the panel shall serve 
16for a term of 3 years.  Any vacancy on the panel must be filled in the same manner as the 
17original appointment but for the unexpired term.
183.  Meetings.  The panel shall meet at such time or times as may be reasonably 
19necessary to carry out its duties, but it shall meet at least twice per year.  The panel's chair 
20shall call the first meeting before July 1, 2020.
214.  Powers and duties.  The panel shall examine a subset of the deaths associated 
22with accidental drug overdoses.  The deaths selected for review must be recommended by 
23the Chief Medical Examiner or the Chief Medical Examiner's designee or by an 
24individual with whom the Office of the Attorney General contracts for services.  
25Notwithstanding any provision of law to the contrary, the panel may review information 
26surrounding an accidental drug overdose that was not fatal, as long as review of such a 
27case promotes the purpose of the panel under this section.  The panel shall recommend to 
28state, county and local agencies methods of preventing deaths as the result of accidental 
29drug overdoses including modification or enactment of laws, rules, policies and 
30procedures.
315.  Access to information, records and materials.  The panel may request and 
32receive confidential criminal history record information as defined by Title 16, section 
33703, subsection 2 and public criminal history record information as defined by Title 16, 
34section 703, subsection 8 from the Department of Public Safety.  In any case subject to 
35review by the panel, upon oral or written request of the panel, notwithstanding any 
36provision of law to the contrary, any person that possesses information or records that are 
37necessary and relevant to a panel review shall as soon as practicable provide the panel 
38with the information and records.  Persons disclosing or providing information or records 
39upon request of the panel are not criminally or civilly liable for disclosing or providing 
40information or records in compliance with this subsection.
Page 3 - 129LR3253(01)-116.  Confidentiality.  The proceedings and records of the panel are confidential and 
2are not subject to subpoena, discovery or introduction into evidence in a civil or criminal 
3action.  The Office of the Attorney General shall disclose conclusions of the panel upon 
4request, but may not disclose information, records or data that are otherwise classified as 
5confidential.
67.  Noninterference.  A review by the panel under this section is subject to and may 
7not interfere with the authority and responsibility of the Attorney General to investigate 
8and prosecute homicides pursuant to Title 5, section 200-A.
9Emergency clause.  In view of the emergency cited in the preamble, this 
10legislation takes effect when approved.
11SUMMARY
12This bill establishes the Accidental Drug Overdose Death Review Panel to review a 
13select number of deaths caused by accidental drug overdoses and to recommend to state, 
14county and local agencies methods of preventing deaths as the result of accidental drug 
15overdoses including modification or enactment of laws, rules, policies and procedures.
